Tuesday, March 17, 2026

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

U.S. Launches Section 301 Probe, Auto Industry on Alert: “Limited Immediate Impact but Closely Monitoring”

Trade risks for Asia's auto industry rise as U.S. launches a Section 301 investigation, prompting concerns over potential tariffs.

IAEA Chief Raises Concerns Over North Korea’s Nuclear Maneuvers

The IAEA has stated that operation signs continue to be observed at the experimental light water reactor in North Korea.

Seo Yeon Kang

Author's Latest

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.